Low efficiency of the Moloney murine leukemia virus reverse transcriptase during reverse transcription of rare t(8;21) fusion gene transcripts

被引:33
作者
Curry, J [1 ]
McHale, C [1 ]
Smith, MT [1 ]
机构
[1] Univ Calif Berkeley, Dept Immunol Mol & Cellular Biol, Berkeley, CA 94720 USA
关键词
D O I
10.2144/02324st02
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The resolving power of RT-PCR is limited by the efficiency of RNA-to-cDNA conversion. Methods to determine this efficiency, using a real-time PCR assay for quantifying AML1-MTG 8 [t(8;21)] fusion gene transcripts, are described. The efficiency is shown to be directly proportional to RNA template levels. The Moloney murine leukemia virus (MMLV) reverse transcriptase enzyme's conversion efficiency was calculated to be approximately 20%. The efficiency was even lower (6%) when target templates were rare (single molecules) in the RT reactions. Levels of nonspecific or background RNA present in the RT reaction reduced the reverse transcriptase's conversion efficiency. This background effect was particularly pronounced when the specific template was present in rare amounts.
引用
收藏
页码:768 / +
页数:5
相关论文
共 9 条
[1]  
Amabile M, 2001, HAEMATOLOGICA, V86, P252
[2]   Real-time reverse transcription polymerase chain reaction detection and quantification of t(1;19) (E2A-PBX1) fusion genes associated with leukaemia [J].
Curry, JD ;
Glaser, MC ;
Smith, MT .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (04) :826-830
[3]   Leukemias related to treatment with DNA topoisomerase II inhibitors [J].
Felix, CA .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (05) :525-535
[4]   Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia [J].
Kondo, M ;
Kudo, K ;
Kimura, H ;
Inaba, J ;
Kato, K ;
Kojima, S ;
Matsuyama, T ;
Horibe, K .
LEUKEMIA RESEARCH, 2000, 24 (11) :951-956
[5]   Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay [J].
Marcucci, G ;
Livak, KJ ;
Bi, W ;
Strout, MP ;
Bloomfield, CD ;
Caligiuri, MA .
LEUKEMIA, 1998, 12 (09) :1482-1489
[6]  
Sugimoto T, 2000, AM J HEMATOL, V64, P101, DOI 10.1002/(SICI)1096-8652(200006)64:2<101::AID-AJH5>3.0.CO
[7]  
2-X
[8]   Molecular monitoring of minimal residual disease in acute myeloblastic leukemia with t(8;21) by RT-PCR [J].
Tobal, K ;
Yin, JAL .
LEUKEMIA & LYMPHOMA, 1998, 31 (1-2) :115-120
[9]   Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease -: Report of the BIOMED-1 Concerted Action:: Investigation of minimal residual disease in acute leukemia [J].
van Dongen, JJM ;
Macintyre, EA ;
Gabert, JA ;
Delabesse, E ;
Rossi, V ;
Saglio, G ;
Gottardi, E ;
Rambaldi, A ;
Dotti, G ;
Griesinger, F ;
Parreira, A ;
Gameiro, P ;
Diáz, MG ;
Malec, M ;
Langerak, AW ;
San Miguel, JF ;
Biondi, A .
LEUKEMIA, 1999, 13 (12) :1901-1928